Immunovant Stock Plunges On $200M Equity Investment From Roivant To Support IMVT-1401 Development

  • Immunovant Inc IMVT has received a $200 million strategic investment from Roivant Sciences that the Company will use to advance IMVT-1401 in multiple indications.
  • Roivant has purchased around 17 million shares of Immunovant's shares at $11.75 per share. 
  • After giving effect to the investment, Immunovant has a pro forma cash balance of approximately $600 million, and Roivant has increased its ownership stake in Immunovant from 57.5% to 63.8%.
  • IMVT-1401, a fully human anti-FcRn monoclonal antibody, is Immunovant's lead candidate.
  • "We are excited to announce this significant investment by Roivant, which will expedite our development of IMVT-1401 for a wide range of autoimmune disorders," said Dr. Pete Salzmann, Chief Executive Officer of Immunovant. "Over the next 12 months, we plan to initiate a pivotal trial for myasthenia gravis, resume our trials in WAIHA and TED and initiate at least two additional clinical studies, including another pivotal trial in 2022."
  • Price Action: IMVT shares are down 24.5% at $7.90 during the premarket session on the last check Monday.

Posted In: BriefsBiotechNewsShort IdeasHealth CareFinancingOfferingsSmall CapMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.